Global IVF Time-lapse Imaging System Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
IVF time-lapse imaging system is a way of embryo morphological assessment of assisted reproductive technology. It mainly uses time-lapse imaging technology to take real-time photographs of embryos in vitro culture environment, usually the shooting interval set by jet lag imaging technology is 5 minutes for each photo, and the entire acquired embryo digital picture is converted into a dynamic growth video, which constitutes a growth file of the embryo development, so that the entire embryo development process can be recorded completely and in detail. After applying this technique, embryologists can continuously observe the entire dynamic development process through video images without removing the embryos from the incubator, and obtain kinetic parameters that predict the potential of embryonic development, providing a strong reference for selecting embryos suitable for transfer. Embryo transfer using the kinetic parameters provided by the IVF time-lapse imaging system combined with morphological selection can improve embryo implantation and clinical pregnancy rates.
Market Overview:The latest research study on the global IVF Time-lapse Imaging System market finds that the global IVF Time-lapse Imaging System market reached a value of USD 85.4 million in 2022. It’s expected that the market will achieve USD 232.95 million by 2028, exhibiting a CAGR of 18.2% during the forecast period.
Economic downturns can lead to a decrease in disposable income and make IVF treatment less affordable for couples. The high cost of IVF treatment can be a significant barrier to adoption, and economic downturns can exacerbate this problem. Additionally, during economic downturns, people may be more likely to delay starting a family, which can also limit the demand for IVF time-lapse imaging systems. As a result, the IVF time-lapse imaging system market may experience a decline in demand during economic downturns, which can impact the growth of the market.
Growing awareness and acceptance of IVF
In the past, there was a social stigma attached to infertility and IVF treatment, which led many couples to avoid seeking help. However, in recent years, there has been a shift in societal attitudes towards infertility and IVF treatment. More people are recognizing infertility as a medical condition that requires treatment, and IVF is increasingly being seen as a viable option for starting a family.
This growing acceptance of IVF has led to an increase in demand for IVF treatment, which in turn is driving the growth of the IVF time-lapse imaging system market. IVF time-lapse imaging systems are an essential part of IVF treatment, as they allow embryologists to monitor the development of embryos in real-time and select the most viable embryos for transfer.
Economic downturns
Economic downturns can lead to a decrease in disposable income and make IVF treatment less affordable for couples. The high cost of IVF treatment can be a significant barrier to adoption, and economic downturns can exacerbate this problem. Additionally, during economic downturns, people may be more likely to delay starting a family, which can also limit the demand for IVF time-lapse imaging systems. As a result, the IVF time-lapse imaging system market may experience a decline in demand during economic downturns, which can impact the growth of the market.
Cultural and religious barriers
Cultural and religious barriers can be a significant challenge for the adoption of IVF time-lapse imaging systems in some countries or among certain patient groups. For example, in some cultures or religions, there may be stigmas associated with infertility, which can make it difficult for couples to seek medical help for their condition. Additionally, some religions may have moral objections to the use of assisted reproductive technologies such as IVF, which can limit the adoption of these technologies among certain patient groups.
It's important to note that cultural and religious barriers vary by country and by individual beliefs, and some countries have made significant progress in overcoming these barriers through education and awareness campaigns. However, these barriers can still be a significant challenge for some patients, particularly in countries where infertility is stigmatized or where there are strong religious or cultural objections to assisted reproductive technologies.
Region Overview:Asia Pacific had the highest growth rate of all regions in 2022.
In 2022, the share of the IVF Time-lapse Imaging System market in Europe stood at 38.30%.
Company Overview:Vitrolife Sweden AB is one of the major players operating in the IVF Time-lapse Imaging System market, holding a share of 55.97% in 2023.
Vitrolife Sweden AB
Vitrolife Sweden AB is a medical device company. It develops, produces, and markets products for creating, prolonging, and improving life. The company's product categories include Oocyte retrieval Needles; Sperm processing; IVF media and oil; Micromanipulation pipettes; Labware; Benchtop incubators; Time-lapse systems; Preimplantation Genetic Testing (PGT); Cryopreservation; Laser and imaging systems, and Lab QC systems.
Genea Biomedx PYT LTD.
Genea Biomedx Pty Ltd. is a biotechnology company that specializes in the development and commercialization of fertility treatment technologies. The company was founded in 1985 as Sydney IVF and rebranded as Genea in 2009. Genea Biomedx provides a range of fertility products and services, including IVF time-lapse imaging systems, embryo biopsy systems, and cryopreservation solutions.
Segmentation Overview:IVF Time-Lapse Imaging System Software refers to a series of embryo decision support tools.
The IVF time-lapse imaging system hardware is the physical equipment used in In Vitro Fertilization (IVF) treatment to capture and record time-lapse images of developing embryos.
The Software segment by type showed a value growth of 13.99% in 2022.
Among different product types, hardware segment is anticipated to contribute the largest market share in 2028.
Application Overview:IVF time-lapse imaging systems have become an essential tool for fertility clinics and hospitals that perform in vitro fertilization procedures.
By application, the hospitals segment occupied the biggest share from 2018 to 2022.
Key Companies in the global IVF Time-lapse Imaging System market covered in Chapter 3:Esco Medical Technologies UAB
ASTEC CO., LTD.
Genea Biomedx PYT LTD.
Vitrolife Sweden AB,
In Chapter 4 and Chapter 14.2, on the basis of types, the IVF Time-lapse Imaging System market from 2018 to 2029 is primarily split into:Software
Hardware
In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the IVF Time-lapse Imaging System market from 2018 to 2029 covers:Hospital
Fertility Clinic
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)